Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Appointments

Set Alert for Appointments

Latest From People

Appointments: Sanofi, Regeneron, Galena, Genmab, Abpro and Myokardia

This week's roundup sees Sanofi appoint Biogen's former SVP of corporate affairs to executive vice president, external affairs. Meanwhile, Galena Biopharma, Abpro, Genmab and Purdue Pharma have all named new executives.

People

Appointments: Avillion, X4 Pharmaceuticals, Summit, Cytovation, Kymab, Ipsen and Sosei

This week's roundup includes the appointments of chief medical officers by both Avillion and X4 Pharmaceuticals and various other senior appointments at Summit Therapeutics, Sosei, Ipsen and Kymab.

People BioPharmaceutical

J.P. Morgan Executive Roundtable, Part 2: Women In Biopharma And The Path Forward

Women fill many roles in biopharma companies, but relatively few are in leadership positions. Executives who spoke with Scrip in a roundtable discussion during the J.P. Morgan Healthcare Conference earlier this month noted the disconnect, but saw some hope for improved gender diversity in the future.

Business Strategies Leadership

Aiming To Lead A Global Operation? Start In China!

Moving from China president to a CEO, from regional Asia head to a global pharmaceutical president, several recent senior executive appointments have people wondering if China is increasingly becoming the new launch pad for high flyers eyeing a global pharma leadership role.

People Strategy

J.P. Morgan Executive Roundtable, Part 1: How To Help Women Move Into The Biopharma C-Suite

Scrip decided to shake things up a bit for its third annual biopharmaceutical executive roundtable held during the J.P. Morgan Healthcare Conference by putting together an all-female panel to talk about the financing and dealmaking landscape as well as the state of women in the industry.

Leadership Business Strategies

Appointments: Adherium, Pharmalink, Cleave Biosciences, Decibel, Minoryx, Oxular and Aelix

This week's roundup includes board appointments by Pharmalink, Oxular, Decibel Therapeutics and executive appointments by various companies including e-Therapeutics, where Amgen's current executive director of corporate development has been appointed CEO, Cleave Biosciences and IXICO.

People BioPharmaceutical

GSK Management Shake Up Ahead Of New CEO Sees Hussain Out, AZ's Miels In

"Succession processes are challenging for everyone involved and, unfortunately, it is rare that all of those involved stay with the company," stated GSK's out-going CEO Andrew Witty, as Abbas Hussain decides to leave the company having lost out on the top job, which went to Emma Walmsley. His successor will be AstraZeneca's Luke Miels.

Companies Commercial

Pharma Executives To Watch In China In 2017

From general managers of multinationals to new CEOs of domestic innovative startups, a string of recently minted executives will help shape the future of the pharma industry in China.

People China

Sobi Seeks New CEO Who Is Around Sweden, Europe As Business Grows

Sobi's outgoing US-based CEO says his extended handover will “maintain continuity” as Sweden's rare disease specialist searches for a successor who will "stay closer to home" as it conducts key product launches.

People Companies

Appointments: Shire, Bicycle Therapeutics, Gilead Sciences, Astellas, Alzheon, Alnylam and Amplyx

2017 begins with three Novartis executives finding new roles and high-level appointments made by Shire, Bicycle Therapeutics, Gilead Science and Amplyx Pharmaceuticals.

People BioPharmaceutical

Lilly Management Reorg Brings In Shaw To Oversee Bio-Medicines

Shaw is the former US President of rival Novartis and a rising figure in big pharma. She will take over the role previously held by Ricks, who became CEO Jan. 1. Conterno will assume President USA role.

Leadership People

Scrip's Pharma Influencers Of 2016

The Scrip editorial team have put their heads together to make a list of the people that we believe have shaped the biopharma industry in 2016 – in terms of reputation, innovation or commercialization. In the way of Time magazine's 'Person of the Year', inclusion on the list is not necessarily an accolade…

People Commercial
See All
UsernamePublicRestriction

Register